Axcend

Provo, United States Founded: 2018 • Age: 8 yrs Acquired By Catalyze
Compact nanoflow liquid chromatography systems are provided for analytical use.

About Axcend

Axcend is a company based in Provo (United States) founded in 2018 was acquired by Catalyze in July 2024. It operates as a Direct-to-Consumer (D2C). Axcend has raised $3.55 million across 8 funding rounds from investors including HHS, National Institute of General Medical Sciences and Catalyze Partners. The company has 8 employees. Axcend offers products and services including Axcend Focus LC, Auto Focus, In Focus, and Focus Array.

  • Headquarter Provo, United States
  • Employees 8
  • Sectors
    Chemicals & Materials
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website axcendcorp.com
  • Social LinkedIn X Facebook
  • Acquired by Catalyze (Jul 2024)
  • Legal Name Axcend
Key Metrics
  • Total Equity Funding
    $3.55 M (USD)

    in 8 rounds

  • Latest Funding Round
    $1.12 M (USD), Grant

    Sep 2022

  • Investors
    HHS

    & 2 more

  • Employee Count
    8
  • Acquired by
    Catalyze

    (Jul 2024)

Products & Services of Axcend

Axcend offers a comprehensive portfolio of products and services, including Axcend Focus LC, Auto Focus, In Focus, and Focus Array.

Axcend Focus LC
HPLC Systems

Compact HPLC system for flexible, repeatable results anywhere.

Auto Focus
HPLC Systems

Automated sample injection for consistent, low carry-over results.

In Focus
HPLC Systems

Real-time reaction monitoring for precise process analytical technology.

Focus Array
HPLC Systems

Smallest DAD for enhanced capillary HPLC detection sensitivity.

Funding Insights of Axcend

Axcend has successfully raised a total of $3.55M across 8 strategic funding rounds. The most recent funding activity was a Grant round of $1.12 million completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $3.5M
  • Total Rounds 8
  • Last Round Grant β€” $1.1M
  • First Round $1.0M

    (Jun 2018)

  • Investors Count 2

All 8 funding rounds of Axcend with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2022$1.1MGrant––
Mar 2021–Grant––
Mar 2021$750,000Debt – Conventional––
–
May 2020$1.7MGrant––
Mar 2020$1.7MDebt – Conventional––
–
May 2019$2.5MSeed––
–
Sep 2018$135,024Grant––
Jun 2018$1.0MSeed––
–
Valuation history

3 investors in total: 3 institutional.

Investors in Axcend

Axcend has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include HHS, National Institute of General Medical Sciences and Catalyze Partners.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Public health and human services are overseen by HHS.
1953hhs.gov-
Basic research is supported to advance medical sciences.
–nigms.nih.govBethesda, United States
Commercialization of high-tech innovations and monetization of assets is facilitated by Catalyze Partners.
–catalyze.partners-
Premium access

Investor details for Axcend

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Axcend

4 dated milestones of Axcend across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded Axcend is founded.
  2. Funding First funding round of $1.0M.
  3. Funding Latest funding round, Grant, of $1.1M.
  4. Exit Acquired by Catalyze.

Web traffic of Axcend

The website of Axcend (axcendcorp.com) receives about 2.8K visits a month.

  • Monthly visits
    2.8K

    ▲ 22.5% vs previous month

Similar companies to Axcend

10 companies that operate in the same segment as Axcend (Petrochemicals & Derivatives), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Aramco is recognized as a leading producer of energy and chemicals globally.
1993Dhahran, Eastern Province, Saudi Arabia–––
Petrochemicals, chemicals, and thermoplastic resins are produced for businesses.
2002Sao Paulo, Brazil–USD 12.91 B8,380
Produces and supplies specialty chemicals for energy, petrochemicals, and industrial applications worldwide.
1992Mumbai, Maharashtra, India–USD 479.49 M976
Lubricants, additives, vehicle care, and repair liquids are manufactured.
1957Ulm, Baden-wurttemberg, Germany–––
PET resins, PET products, and wool yarn are manufactured.
1994Bangkok, Thailand–USD 14.12 B175
Polybutene-based petrochemicals are produced by the company.
1990Chennai, Tamil Nadu, India–USD 62.67 M194
Petrochemicals and derivatives are manufactured in Thailand.
2011Rayong, Thailand–USD 15.39 B–
Petrochemical products are manufactured and supplied by SCGC.
1994Bangkok, Thailand–USD 35.91 M–
Petrochemical products and materials are supplied globally for key industries.
1957Tokyo, Tokyo, Japan–USD 750.07 K–
Refined fuels, polymers, and monomers are produced for industrial applications.
2005Rabigh, Makkah Region, Saudi Arabia––2,944
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Axcend

Axcend was founded in 2018.

Axcend is headquartered in Provo, United States. It is registered at Provo, Utah, United States.

Axcend is a funded company, having raised a total of $3.55M across 8 funding rounds to date. The company's 1st funding round was a Seed of $1M, raised on Jun 2018.

Axcend has 8 employees.

Axcend is known for creating compact, low-flow HPLC systems that deliver reliable chromatography results in various settings. These systems are designed for industries such as pharmaceutical, chemical, and educational sectors. Solutions offered by Axcend include real-time monitoring, automated sample injection, and high-sensitivity detection, reducing solvent use, energy consumption, and waste. Their technology is adapted for tight lab spaces or remote locations, supporting sustainability and operational efficiency.

Axcend offers Axcend Focus LC, Auto Focus, In Focus, and Focus Array.

Axcend has 3 investors. Key investors include HHS, National Institute of General Medical Sciences, and Catalyze Partners.

Axcend operates through Axcend.

Yes. Axcend was acquired by Catalyze in July 2024.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available